Medipal Holdings (TSE:7459) Days Sales Outstanding : 77.92 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Medipal Holdings Days Sales Outstanding?

Medipal Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was 円799,178 Mil. Medipal Holdings's Revenue for the three months ended in Dec. 2023 was 円935,926 Mil. Hence, Medipal Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 77.92.

The historical rank and industry rank for Medipal Holdings's Days Sales Outstanding or its related term are showing as below:

TSE:7459' s Days Sales Outstanding Range Over the Past 10 Years
Min: 77.2 Med: 79.93 Max: 87.23
Current: 80.88

During the past 13 years, Medipal Holdings's highest Days Sales Outstanding was 87.23. The lowest was 77.20. And the median was 79.93.

TSE:7459's Days Sales Outstanding is ranked worse than
55.21% of 96 companies
in the Medical Distribution industry
Industry Median: 77.31 vs TSE:7459: 80.88

Medipal Holdings's Days Sales Outstanding declined from Dec. 2022 (78.77) to Dec. 2023 (77.92).

Medipal Holdings Days Sales Outstanding Historical Data

The historical data trend for Medipal Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipal Holdings Days Sales Outstanding Chart

Medipal Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

79.41

77.20

79.07

78.45

78.31

Medipal Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															78.77	87.05	77.42	79.73	77.92

Competitive Comparison of Medipal Holdings's Days Sales Outstanding

For the Medical Distribution subindustry, Medipal Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medipal Holdings's Days Sales Outstanding Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Medipal Holdings's Days Sales Outstanding falls into.

Medipal Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Medipal Holdings's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (712498	+	729340)	/	2 )	/	3360008	*	365
=	720919					/	3360008	*	365
=	78.31

Medipal Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (783876	+	814480)	/	2 )	/	935926	*	365 / 4
=	799178					/	935926	*	365 / 4
=	77.92

Medipal Holdings (TSE:7459) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Medipal Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Medipal Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipal Holdings (TSE:7459) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medipal Holdings Corp (TSE:7459) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

MEPDF:USA MAHLY:USA 59Z:Germany

Address

2-7-15, Yaesu, Chuo-ku, Tokyo, JPN, 104-8461

Website

http://www.medipal.co.jp

Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Medipal Holdings (TSE:7459) Headlines

No Headlines